Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
Clinical trial NCT05118841 · UNKNOWN
Trial details
- NCT number
- NCT05118841
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-03
- Primary completion
- 2023-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.